Key Facts & Findings
- Global healthy life expectancy (HALE) trailed life expectancy by roughly 9.7 years as of the most recent comparable estimate, and the gap has widened since at least 1995.
- The number of people aged 80 and older is projected to exceed the global infant population by the mid-2030s, concentrating future disability-related care needs at the oldest ages where prevalence is highest.
- By the late 2050s, more than half of global deaths are projected to occur at age 80 or older, up from just 17% in 1995.
- WHO data show global HALE fell from about 63.7 years (2019) to 61.9 years (2021) during the COVID-19 pandemic, illustrating the sensitivity of healthspan to acute shocks.
- Chronic and degenerative conditions, cardiovascular disease, musculoskeletal limitations, sensory and cognitive decline, dominate years lived with disability globally, more than infectious disease.
- Socioeconomic, regional, and ethnic disparities in healthy life expectancy are substantial even within high-income countries with strong average outcomes.
Between 1995 and 2017, global life expectancy rose from 66.2 to 73.0 years, a gain of 6.8 years. Over the same period, healthy life expectancy rose from 57.6 to 63.3 years, a gain of only 5.7 years. The difference between those two gains is the story: the world is adding years of life faster than it is adding years of health, and the gap between the two, currently estimated at 9.7 years globally and still widening, is quietly becoming a more consequential demographic fact than life expectancy itself.
This distinction rarely makes headlines the way raw life expectancy figures do, but it is the variable that actually determines how much care, disability support, and dependency-related spending an aging population will require. A country where people live to 85 with 80 healthy years faces a fundamentally different demographic future than one where people live to 85 with 70 healthy years, even though both report identical life expectancy.
What Is Healthy Longevity?
Healthy longevity is typically measured using health-adjusted life expectancy (HALE), a metric that combines mortality data with the prevalence and severity of disability and chronic illness to estimate the number of years a person can expect to live in full health, as opposed to years lived with some degree of functional limitation.
The World Health Organization’s HALE figures, and the closely related Global Burden of Disease Study estimates produced by the Institute for Health Metrics and Evaluation (IHME), are the two primary international data sources tracking this measure, and they show broadly consistent country rankings even where specific figures differ slightly by methodology.
The related but distinct concept of disability-free life expectancy narrows the focus further, measuring years lived without any functional disability at all, a stricter threshold than HALE, which allows for some health-adjusted weighting of partial disability.
The Longevity-Healthspan Gap
The gap between life expectancy and HALE, sometimes called the “unhealthy life expectancy” or health-expectancy gap, represents the average number of years a person can expect to live with some degree of disability, chronic disease, or diminished function.
Global tracking from 1995 through the mid-2020s shows this gap has consistently widened even as both underlying figures rose, a pattern researchers attribute partly to medical advances that extend survival with chronic conditions without necessarily curing them, meaning more people live longer with diseases that, in earlier decades, would have been fatal at a younger age.
The COVID-19 pandemic offered a sharp, real-time illustration of how quickly this gap can move: WHO data show global HALE fell from roughly 63.7 years in 2019 to 61.9 years in 2021, even as overall life expectancy dropped by a comparable margin, demonstrating how acute health shocks compress both figures together before recovery resumes.
Why Population Aging Changes the Equation
As the population of older adults grows, and grows disproportionately at the oldest ages, the total volume of years lived with disability or chronic illness rises even if the rate of disability at any given age stays constant. The UN Population Division projects that the number of people aged 80 and older will exceed the global infant population by the mid-2030s, and that more than half of all deaths worldwide will occur at age 80 or older by the late 2050s, up from just 17% in 1995. Since disability prevalence rises steeply with age, particularly past 80, this shift in the age structure of mortality is itself a strong signal that the aggregate demand for disability-related care and support will grow faster than population aging alone would suggest.
Global Life Expectancy vs. Healthy Life Expectancy, Selected Years
| Year | Global Life Expectancy | Global HALE | Health-Expectancy Gap |
|---|---|---|---|
| 1995 | 66.2 years | 57.6 years | 8.6 years |
| 2017 | 73.0 years | 63.3 years | 9.7 years |
| 2019 (pre-pandemic) | ~73.3 years | ~63.7 years | ~9.6 years |
| 2021 (pandemic trough) | 71.4 years | 61.9 years | 9.5 years |
| 2024 | 73.3 years | Not yet finalized | Projected ~9.7–10 years |
Which Conditions Shape Later Life?
Without turning into a clinical guide, it is worth noting at a population level that the conditions most responsible for widening the healthspan gap are chronic and degenerative rather than acute: cardiovascular disease, musculoskeletal conditions limiting mobility, sensory decline, and cognitive impairment are consistently among the largest contributors to years lived with disability in Global Burden of Disease research, alongside a substantial contribution from mental health conditions across the life course. The relative weight of each cause varies significantly by region and income level, but the general pattern, chronic rather than infectious disease driving the bulk of disability-adjusted life years at older ages, holds globally.
Healthy Longevity Differs by Population
Healthy life expectancy is not distributed evenly:
- By sex. Women consistently have higher life expectancy than men in nearly every country, but research also shows women often spend a larger share of their longer lives with some degree of disability, meaning the female longevity advantage does not translate proportionally into a healthspan advantage.
- By income and education. Socioeconomic inequalities in life expectancy are well documented; Australian data, for example, show life expectancy rising consistently across more advantaged socioeconomic deciles, a pattern replicated in most countries with disaggregated health data.
- By geography. HALE varies substantially by region even within single countries, regional data from the Americas show a gap of roughly 5.3 years in HALE between the highest- and lowest-performing subregions.
- By ethnicity, where data permits. In Australia, life expectancy for Aboriginal and Torres Strait Islander people remains 8 to 9 years lower than for non-Indigenous Australians, illustrating how healthspan inequality can be substantial even within high-income countries with strong average life expectancy.
- Urban versus rural residence. Access to healthcare, environmental conditions, and occupational exposure typically produce measurable urban-rural gaps in both life expectancy and healthy life expectancy, though the direction and size of the gap varies by country and region.
The Demographic Consequences
The size of the lifespan-healthspan gap directly shapes several downstream demographic and economic outcomes covered elsewhere in this dataset:
- Care demand. A wider gap means more years of intensive care need per person, amplifying pressure on both family caregivers and paid care workforces, as detailed in analysis of the global care economy.
- Pension duration versus healthy working years. A narrower gap allows more people to remain economically active for a larger share of their extended lifespan, partially offsetting pension cost pressure.
- Household caregiving burden. Longer years of disability translate directly into more unpaid caregiving hours provided by family members, a dynamic explored in coverage of the hidden costs of living longer.
- Long-term care and public expenditure. OECD projections showing long-term care spending nearly doubling by 2050 are driven substantially by growth in the population living with age-related functional limitations, not simply by population aging in the abstract.
Can Healthspan Increase Faster Than Lifespan?
Two competing hypotheses run through the research literature. The “compression of morbidity” hypothesis holds that medical and public health advances can compress the period of disability into a shorter span near the end of life, allowing healthspan to grow roughly in step with, or even faster than, lifespan. The competing “expansion of morbidity” hypothesis holds that medical advances primarily extend survival with chronic disease rather than preventing it, meaning lifespan grows faster than healthspan and the unhealthy years simply get pushed later rather than compressed.
The historical data on the widening health-expectancy gap since 1995 lends more support to an expansion-of-morbidity pattern globally to date, though outcomes vary by country, and neither hypothesis is settled as a universal rule, recent modeling by IHME projecting life expectancy gains through 2050 suggests both life expectancy and HALE will continue rising, without resolving definitively which will rise faster on a global average basis.
What the Future Population May Look Like
Scenario-based projections, as opposed to fixed forecasts, suggest that the size of the future care-dependent population will depend heavily on which of the two hypotheses above proves more accurate at scale, and on how much further investment flows into preventive health, chronic disease management, and rehabilitative care.
IHME modeling projecting mortality and disability trends through 2050 anticipates continued global life expectancy gains alongside a narrowing of geographic disparities, with the largest improvements concentrated in sub-Saharan Africa, but such projections carry substantial uncertainty and should be read as plausible scenarios rather than guaranteed trajectories.
Conclusion
Raw life expectancy tells only half the demographic story of an aging world; the other half is written in the widening gap between lifespan and healthspan. That gap, nearly a decade globally and growing, is what actually determines how much care a population will need, how long people can remain economically active, and how heavily longevity will weigh on families and public budgets.
As the population aged 80 and older approaches parity with the global infant population within the next decade, closing rather than widening the health-expectancy gap will do more to shape the next several decades of demographic change than any single policy aimed at extending lifespan alone.
Frequently Asked Questions
1. What is healthy longevity?
It refers to years of life lived in good health, typically measured through health-adjusted life expectancy (HALE), which accounts for time spent with disability or chronic illness rather than counting all years of survival equally.
2. What is the difference between lifespan and healthspan?
Lifespan is total years lived; healthspan is the portion of those years lived in good functional health. The gap between them represents years lived with some degree of disability or chronic illness.
3. Why does healthy life expectancy matter more than life expectancy alone?
Because it more accurately predicts the volume of care, disability support, and healthcare spending a population will require, two countries with identical life expectancy can have very different care burdens depending on their HALE.
4. Does living longer always mean living less healthy for longer?
Not necessarily, but current global data show the health-expectancy gap has been widening rather than narrowing since 1995, suggesting that on average, lifespan gains have outpaced healthspan gains to date.
5. How does healthspan affect population aging pressures?
A narrower healthspan gap allows more of an aging population to remain independent and economically active longer, easing pressure on care systems and pension financing compared with a population where longevity gains arrive mostly as added years of dependency.
6. Which age group matters most for future care demand?
The population aged 80 and older, since disability prevalence rises steeply at these ages and this group is projected to grow faster than any other age segment globally.
7. Are healthy life expectancy gaps the same everywhere?
No. HALE varies by sex, income, education, geography, and ethnicity, with documented gaps of several years even within single high-income countries.
8. What causes most years lived with disability globally?
Chronic and degenerative conditions, including cardiovascular disease, musculoskeletal limitations, and cognitive and sensory decline, account for the largest share, more than infectious disease, according to Global Burden of Disease research.
9. Can healthspan increase faster than lifespan in the future?
It remains an open empirical question. The “compression of morbidity” hypothesis suggests it is possible with continued public health investment; historical data since 1995 has generally shown the opposite pattern globally to date.
10. What data sources track healthy life expectancy globally?
The World Health Organization and the Institute for Health Metrics and Evaluation’s Global Burden of Disease Study are the two primary sources, using related but not identical methodologies.
Sources
- World Health Organization, World Health Statistics 2024.
- “A comparative, correlate analysis and projection of global and regional life expectancy, healthy life expectancy, and their GAP: 1995–2025,” PMC/NIH.
- United Nations, World Population Prospects 2024: Summary of Results, UN DESA Population Division.
- PAHO, “Health-adjusted life expectancy (HALE),” Americas regional analysis.
- Australian Bureau of Statistics, “Life expectancy,” Measuring What Matters.
- Institute for Health Metrics and Evaluation (IHME), Global Burden of Disease projections to 2050.
